When combined with serum AFP detection (AFP > 20 ng/mL), the sensitivity/specificity of aberrant fucosylation test for HCC improved to 78/88%, 85/88%, and 89/91% in all serum samples, HBV-associated chronic liver diseases and HBV-associated cirrhosis, respectively. The gene discussed is AFP; the disease is hepatocellular carcinoma.